Traumatic brain injury future or investigational therapies: Difference between revisions
No edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
In spite of robust experiments on the efficacy of neuroprotective drugs tested in animal models of traumatic brain injury, all Phase III clinical trials of neuroprotection have failed in patients with traumatic brain injury. | |||
==Future Or Investigational Therapies== | ==Future Or Investigational Therapies== | ||
In spite of robust experiments on the efficacy of neuroprotective drugs tested in animal models of traumatic brain injury, all Phase III clinical trials of neuroprotection have failed in patients with traumatic brain injury.<ref name="pmid19249984">{{cite journal| author=Xiong Y, Mahmood A, Chopp M| title=Emerging treatments for traumatic brain injury. | journal=Expert Opin Emerg Drugs | year= 2009 | volume= 14 | issue= 1 | pages= 67-84 | pmid=19249984 | doi=10.1517/14728210902769601 | pmc=2773142 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19249984 }} </ref><ref name="pmid25727893">{{cite journal| author=Xiong Y, Zhang Y, Mahmood A, Chopp M| title=Investigational agents for treatment of traumatic brain injury. | journal=Expert Opin Investig Drugs | year= 2015 | volume= 24 | issue= 6 | pages= 743-60 | pmid=25727893 | doi=10.1517/13543784.2015.1021919 | pmc=4433440 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25727893 }} </ref> | |||
==References== | ==References== | ||
Latest revision as of 19:53, 16 September 2020
|
Traumatic brain injury Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Traumatic brain injury future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Traumatic brain injury future or investigational therapies |
|
FDA on Traumatic brain injury future or investigational therapies |
|
CDC on Traumatic brain injury future or investigational therapies |
|
Traumatic brain injury future or investigational therapies in the news |
|
Blogs on Traumatic brain injury future or investigational therapies |
|
Risk calculators and risk factors for Traumatic brain injury future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Joanna Ekabua, M.D. [2]
Overview
In spite of robust experiments on the efficacy of neuroprotective drugs tested in animal models of traumatic brain injury, all Phase III clinical trials of neuroprotection have failed in patients with traumatic brain injury.
Future Or Investigational Therapies
In spite of robust experiments on the efficacy of neuroprotective drugs tested in animal models of traumatic brain injury, all Phase III clinical trials of neuroprotection have failed in patients with traumatic brain injury.[1][2]
References
- ↑ Xiong Y, Mahmood A, Chopp M (2009). "Emerging treatments for traumatic brain injury". Expert Opin Emerg Drugs. 14 (1): 67–84. doi:10.1517/14728210902769601. PMC 2773142. PMID 19249984.
- ↑ Xiong Y, Zhang Y, Mahmood A, Chopp M (2015). "Investigational agents for treatment of traumatic brain injury". Expert Opin Investig Drugs. 24 (6): 743–60. doi:10.1517/13543784.2015.1021919. PMC 4433440. PMID 25727893.